Tagged with Dermatology

Poland Adam Czerw, country manager of LEO Pharma Poland, discusses the impressive growth of the affiliate, especially since the global 2016 purchase of Astellas’ dermatology portfolio, as well as the encouraging development of LEO’s first ever reimbursed product on the Polish market. Furthermore, he highlights the key steps to further reward…

Canada Wendy Adams, general manager of Galderma Canada, outlines the main achievements of the affiliate since 2013, the best practices she can share with Galderma globally when it comes to managing the company’s three business segments, the strong relationships with dermatologists and other healthcare practitioners she has built, and the significance…

Canada Matthieu Grosfils, general manager of the Canadian affiliate of Laboratoires Expanscience, a European leader in dermocosmetics, discusses the significance behind the establishment of the affiliate in 2015, the strengths of the company’s flagship Mustela® line, and his strategic priorities for the future growth of the affiliate. You joined Laboratoires Expanscience…

Austria Martin Prinz, CTO of Croma-Pharma, a family-owned Austrian aesthetic dermatology company, discusses the evolution of the company over the years and their specialist, ever-expanding portfolio. Additionally, he documents the role of training clinics in establishing a vertical business model and provides an overview of the company’s growing global reach, namely…

Brazil Haig Yeghiaian, country manager of LEO Pharma Brazil, details his strategic mission and objectives since he took over the helm of the affiliate in November 2016 as well as the key opportunities and structural rooms for improvement he identifies within the promising Brazilian dermatology area, before highlighting how he wants…

Switzerland Philippe Held, founder of the innovative Swiss medtech Dermosafe, discusses the origins behind the company’s game-changing digitalized solutions for detecting skin cancer at an early stage, how the rollout of the technology is progressing, and the importance of patient and physician education. You founded DermoSafe around five years ago with…

Austria Karl Peter Schwarz, general manager of the Austrian affiliate of LEO Pharma, an ambitious Danish company leading the way in innovative dermatology treatments, provides an in-depth look into how global partnerships and acquisitions have impacted the strategies and operations of the Austrian affiliate. Equally, he provides an insight into how…

Colombia David Torres, general manager of NAOS Colombia, one of the country’s most innovative firms, discusses the inherent challenges in the skincare industry and the specificities of the Colombian market, while highlighting the importance of institutional collaboration to raise skin-related issues and the affiliate’s priorities to further expand its footprint in…

USA In 2016, rumours of a weakening FDA followed a disappointing 16 new drugs approved for the full year. However, since the beginning of 2017 the FDA has approved 26 drugs; double the amount of the mid-year average since 2007. “The eight oncology treatments approved by the FDA this year represent…

Colombia Claudio Ferrari, General Manager of Scandinavia Pharma, proudly presents some of the latest product launches of the company and shares insights into the strategic role Scandinavia Pharma plays for Mega Pharma, as an ambitious player aiming to figure amongst the top five companies in the Colombian trade market by 2021.…

Indonesia Holger Welters, President Director at Beiersdorf Indonesia, discusses the ambitious growth plan for emerging markets that is propelling the company to new heights and sheds light on the importance of bringing high quality skincare solutions to Indonesia through Nivea® and Hansaplast®. Mr. Welters, you have been President Director of Beiersdorf’s…

Mexico In charge of transforming the Monterrey-based family business of dermatological distribution into a Mexican corporate success story, Carlos de Kruyff, shares some of his most pertinent insights on the industry. He speaks about the company’s history and innovative commercialization scheme, the transformative regulatory landscape today, as well as their role…